Israeli startups raised record $1.4b in Q2

Gett Photo PR

The highest-ever amount raised by the country's startups in a single quarter included $300 million raised by Gett from Volkswagen.

An examination by "Globes" found that Israeli companies raised an all-time record $1.4 billion in the second quarter of the year, compared with $1 billion in the first quarter (according to "Globes" figures) and $1.1 billion in the second quarter of 2015 (according to the IVC). The figures for the second quarter of 2016 include a $300 million investment in Israeli company Gett (formerly GetTaxi) by Volkswagen. This extraordinarily large investment was not strictly speaking a venture capital investment, and if subtracted it provides a slightly more precise picture of venture capital investments in Israeli technology companies.

Even after this investment is subtracted, however, the figures still show no real slowdown: $1.1 billion is similar to the first quarter of 2016 and almost identical to the second quarter of 2015, thereby maintaining the record pace. $2.4 billion was raised in the first half of 2016, compared with $2.1 billion in the corresponding period last year.

Now that the second quarter has come to an end and we have taken a deeper look at the figures, an analysis yields the following results:

The average amount raised per company in the second quarter was $27.9 million, or $12.1 million if the Gett investment is subtracted, $500,000 less than the average in the first quarter. This is more or less the amount of capital an earlier stage company already making initial revenue needs to keep going for 12-18 months. For the first half of the year, the average amount raised per company was $14.1 million, or $12.4 million excluding Gett.

13% of the companies raising money since the beginning of the year were biomedical companies, meaning companies developing drugs or medical equipment or a different medical solution. This means that the majority of available capital for investment is still going to technology companies, because their risk profile is naturally lower. The biomedical companies account for only 10% of the amount raised since the beginning of the year.

Three companies raised over $50 million in the second quarter, compared with four companies in the first quarter - almost the same, but only two compared with four if the Gett investment is excluded. This makes a total of seven companies since the beginning of the year - only 4.2% of all companies raising capital. This figure may indicate a slowdown in the number of potential unicorns - a company value of over $1 billion, which are often successful at raising this amount of money. Gett, which raised $300 million, and Via, which raised $100 million, may be valued in the hundreds of millions of dollars, but they are still far away from $1 billion - at least as of now.

The companies that raised over $50 million jointly accounted for 22% of the total raised in the second quarter and 29% of the amount raised in the first half of the year - in other words, 4% of the companies raised 29% of the total, showing that a very small number of companies receive a substantial proportion of the venture capital funds' investment budget.

86% of the companies raised up to $25 million in the second quarter, meaning that most of the companies that raised capital were just starting out (initial revenue). The proportion was the same for the first half of the year. These companies raised 45% of the total in the second quarter (47% in the first half), showing that there were many small companies and few large companies (although it is important to keep in mind that the bigger a company grows, the less it needs to raise capital, and the proportion of small companies is therefore greater).

Published by Globes [online], Israel business news - www.globes-online.com - on July 3, 2016

© Copyright of Globes Publisher Itonut (1983) Ltd. 2016

Gett Photo PR
Gett Photo PR
Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018